200 Cardinal Way, 3rd Floor
Redwood City, CA 94063
9 articles with Genapsys
Innocoll Biotherapeutics, Genapsys, and Adicet Bio announced today their relocation and expansion plans.
Genapsys Adds to its Leadership Team with Two New Hires
Genapsys, Inc. today announced the additions of Priya Ray and Peter Swider to the Company's leadership team as well as the launch of the company's new branding and corporate website, www.genapsys.com .
GenapSys Welcomes Ryan Walters, Ph.D. as Chief Product Officer
GenapSys, Inc. today announced the appointment of Ryan Walters , Ph.D. as Chief Product Officer.
GenapSys Expands Executive and Leadership Teams with Key New Hires
GenapSys, Inc. today announced the addition of Dana Moss to the Company's executive team, and further expanded the Company's leadership team with the addition of Aric Ledford , and Richard Lyon .
GenapSys™ Announces Additions to the Company's Executive Team
GenapSys, Inc. today announced the additions of Britton Russell , Mary Stewart , and Surekha Karudapuram to its executive team.
GenapSys™ Appoints Three New Members to its Board of Directors
GenapSys, Inc. today announced the appointment of Fredrik Eliasson , Diana McKenzie , and Loretta Cecil to its Board of Directors.
GenapSys Announces $70 Million in Series D Equity Financing and Expansion of its Board of Directors
Capital will enable continued advancement of GenapSys' electronic-based, next-generation sequencing platform
GenapSys Names Jason Myers CEO
GenapSys Inc. (GenapSys), the company behind the world’s first highly accurate, affordable, and accessible gene sequencer, today announced it has named Jason Myers as its Chief Executive Officer, effective February 15, 2021
GenapSys Partners With Twist Bioscience to Bring Next-Generation Sequencing Target Enrichment and Library Preparation to World’s Most Accessible Highly Accurate Sequencer
GenapSys Inc., the company behind the world’s first highly accurate, affordable, and portable gene sequencer, today announced a new OEM partnership with Twist Bioscience, a company enabling customers to succeed through its offering of high-quality synthetic DNA.